GSE146687 2 V 5 ERIBULIN HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE146687 2 V 5 ERIBULIN HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE146687 2 V 5 ERIBULIN HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE146687 2 V 5 ERIBULIN HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE146687 2 V 5 ERIBULIN HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

acetylserotonin O-methyltransferase like

Gene

small integral membrane protein 44

Gene

transmembrane protein 9

Gene

zinc finger CCCH-type containing 13

Gene

DNA polymerase delta 3, accessory subunit

Gene

transmembrane protein 98

Gene

glycine cleavage system protein H

Gene

calcium/calmodulin dependent protein kinase kinase 1

Gene

POU class 4 homeobox 2

  • Gene

    H4 clustered histone 15


  • Gene

    acetylserotonin O-methyltransferase like


  • Gene

    small integral membrane protein 44


  • Gene

    transmembrane protein 9


  • Gene

    zinc finger CCCH-type containing 13


  • Gene

    DNA polymerase delta 3, accessory subunit


  • Gene

    transmembrane protein 98


  • Gene

    glycine cleavage system protein H


  • Gene

    calcium/calmodulin dependent protein kinase kinase 1


  • Gene

    POU class 4 homeobox 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.